Ligand Pharmaceuticals (LGND) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,150.63% |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn | 123.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.80% |
| Dec 31, 2025 | 171.06% |
| Sep 30, 2025 | 1,323.15% |
| Jun 30, 2025 | 148.62% |
| Mar 31, 2025 | -297.12% |
| Dec 31, 2024 | 57.42% |
| Sep 30, 2024 | -99.86% |
| Jun 30, 2024 | -115.73% |
| Mar 31, 2024 | -64.20% |
| Dec 31, 2023 | 69.39% |
| Sep 30, 2023 | 8,180.50% |
| Jun 30, 2023 | -135.31% |
| Mar 31, 2023 | 2,089.35% |
| Dec 31, 2022 | -1,092.11% |
| Sep 30, 2022 | 950.59% |
| Jun 30, 2022 | 111.13% |
| Mar 31, 2022 | 234.33% |
| Dec 31, 2021 | 135.72% |
| Sep 30, 2021 | 491.96% |
| Jun 30, 2021 | 719.68% |
| Mar 31, 2021 | 82.47% |
| Dec 31, 2020 | 410.79% |
| Sep 30, 2020 | 204.21% |
| Jun 30, 2020 | 349.36% |
| Mar 31, 2020 | -99.52% |
| Dec 31, 2019 | -170.02% |
| Sep 30, 2019 | -127.50% |
| Jun 30, 2019 | -108.79% |
| Mar 31, 2019 | 771.93% |
| Dec 31, 2018 | -80.08% |
| Sep 30, 2018 | -57.18% |
| Jun 30, 2018 | 33.89% |
| Mar 31, 2018 | 206.42% |
| Dec 31, 2017 | 56.63% |
| Sep 30, 2017 | 177.68% |
| Jun 30, 2017 | 199.45% |
| Mar 31, 2017 | -30.85% |
| Sep 30, 2016 | -40.21% |
| Jun 30, 2016 | -11.52% |
| Mar 31, 2016 | 345.96% |
| Sep 30, 2015 | 25.94% |
| Jun 30, 2015 | -80.40% |
| Mar 31, 2015 | -94.52% |
| Sep 30, 2014 | -70.10% |
| Jun 30, 2014 | 124.49% |
| Mar 31, 2014 | 376.98% |
| Sep 30, 2013 | 501.90% |
| Jun 30, 2013 | 240.32% |
| Mar 31, 2013 | 460.23% |
| Sep 30, 2012 | 58.29% |
| Jun 30, 2012 | -98.20% |
| Mar 31, 2012 | 65.86% |
| Dec 31, 2011 | 101.99% |
| Sep 30, 2011 | 99.76% |
| Jun 30, 2011 | 99.57% |